Leading biocides company – Tarn Pure – has been acquired by Switzerland-based materials, innovation and hygiene technologies experts HeiQ Plc for £850,000, with the support of our national law firm.

Tarn Pure is one of only three businesses authorised by the European Chemicals Agency (ECHA) and the GB Health and Safety Executive (HSE) to place on the market copper and silver conformed for use as Biocidal Active Substances which may be formulated into Biocidal Products. This technology is used primarily to treat and control water borne pathogens that are harmful to human health. Typical examples include gram negative bacteria such as legionella, ecoli and Pseudomonas.

Founded in 2005, HeiQ creates textile technologies, high-performance surface coatings and polymers, probiotics and consumer healthcare goods. The acquisition will support HeiQ’s position as the key supplier of elemental copper and elemental silver to the wider hygiene industry for use as safe and effective antimicrobials, particularly in the face of changing EU regulations that will see a number of biocides phased out in the coming years.

Subject to adjustments for cash, working capital and debt positions as of closing date consideration for Tarn Pure will be approximately £850,000, with 50% in cash and 50% through the issue of new ordinary shares in HeiQ.

Paul Hardman, partner at Shakespeare Martineau who led the deal, said: “I was delighted to help our client achieve this sale having looked after Tarn Pure for the last 10 years. This is a great deal for both sides. Our client was looking to sell their business as they wished to step back from day to day management, but was keen to see it bought by a company that understands the highly regulated market that Tarn-Pure works in and which will take the technology to a wider market, with potentially significant increase in applications.

Robert Collins, Tarn-Pure’s CEO, said, when announcing the sale: “Tarn-Pure is a small business trading in a complex and highly regulated market place. Finding a buyer of the quality of HeiQ leaves the business in excellent hands for the future. The process of managing the transaction was made much easier by the guidance and advice provide by Shakespeare’s corporate finance team, headed by Paul Hardman, who has been our legal advisor since the current shareholders acquired Tarn-Pure in December 2011.

HeiQ’s EVP Tom Ellefsen said: “The HeiQ group has an impressive product range of antimicrobials. Thanks to the recent acquisitions of RAS Ltd., Life Materials Ltd. and Touchguard’s Patents, HeiQ has built a unique capability to serve the hygiene industry with effective solutions.

The acquisition of Tarn-Pure’s regulatory asset strengthens HeiQ’s ability to offer the market access to Europe and the UK for products containing antimicrobial copper and silver. I expect our sales in silver and copper technologies to significantly grow in 2023 thanks to now one of the strongest regulatory portfolios in the market.

Get In Touch

Paul has over 30 years’ experience, specialising in corporate finance work covering mergers and acquisitions, management buy outs and buy ins, joint venture arrangements and shareholder agreements.

Written By

Published: 3rd February 2023
Area: Corporate & Commercial

How We Can Help

Corporate & Commercial

Our closely-woven practice areas ensure that you can tap into deeply experienced specialists, no matter what challenge or opportunity you face.

Mergers & Acquisitions

Our tenacious team will always act with your business interests in mind, helping you to get the best deal.

Our Latest Corporate Updates

Our experts are here to answer any questions you might have

If you’d like to speak to a member of our team, please fill out the enquiry form. We will aim to reply to your query within 2 hours

Need to talk to someone sooner? You can call using the number below

Call Us: 0330 024 0333